Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
0858.HK Stock Summary
In the News
0858.HK Financial details
Company Rating
Neutral
Market Cap
71.7M
Income
-66.46M
Revenue
133.18M
Book val./share
0.22
Cash/share
0.05
Dividend
-
Dividend %
-
Employees
169
Optionable
No
Shortable
Yes
Earnings
29 Nov 2023
P/E
0.99
Forward P/E
-
PEG
-0.06
P/S
1.51
P/B
0.08
P/C
0.62
P/FCF
-22.53
Quick Ratio
1.83
Current Ratio
3.13
Debt / Equity
1.18
LT Debt / Equity
1.18
-
-
EPS (TTM)
-0.03
EPS next Y
-
EPS next Q
-
EPS this Y
-0.92%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
15.08%
Revenue last 5Y
-4.04%
Revenue Q/Q
-21.68%
EPS Q/Q
-385.1%
-
-
-
-
SMA20
-25%
SMA50
-
SMA100
-25%
Inst Own
-
Inst Trans
-
ROA
7%
ROE
10%
ROC
-0.01%
Gross Margin
44%
Oper. Margin
-13%
Profit Margin
192%
Payout
-
Shs Outstand
2.39B
Shs Float
945.51M
-
-
-
-
Target Price
-
52W Range
0.028-0.07
52W High
-
52W Low
-
RSI
47.3
Rel Volume
0.7
Avg Volume
753.83K
Volume
530K
Perf Week
0%
Perf Month
3.33%
Perf Quarter
-35.42%
Perf Half Y
-38%
-
-
-
-
Beta
0.474
-
-
Volatility
0%, 0%
Prev Close
-8.82%
Price
0.031
Change
6.9%
0858.HK Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-03-31
Metric | History | 2019-03-31 | 2020-03-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0.03 | 0.02 | 0.03 | 0.02 | 0.02 | |
Net income per share | 0.02 | 0.03 | -0.05 | 0.04 | 0.04 | |
Operating cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Free cash flow per share | -0.01 | 0 | 0 | 0 | 0 | |
Cash per share | 0.05 | 0.05 | 0.06 | 0.04 | 0.04 | |
Book value per share | 0.32 | 0.19 | 0.22 | 0.2 | 0.23 | |
Tangible book value per share | 0.32 | 0.19 | 0.22 | 0.2 | 0.23 | |
Share holders equity per share | 0.32 | 0.19 | 0.22 | 0.2 | 0.23 | |
Interest debt per share | 0.02 | 0.18 | 0.25 | 0.19 | 0.19 | |
Market cap | 348.74M | 296.1M | 372.61M | 286.23M | 220.43M | |
Enterprise value | 761.83M | 725.07M | 810.44M | 750.28M | 713.81M | |
P/E ratio | 5.45 | 3.56 | -3.08 | 2.19 | 1.71 | |
Price to sales ratio | 3.91 | 3.82 | 4.73 | 3.87 | 3.04 | |
POCF ratio | -23.11 | -28.87 | -1.61K | -179.01 | 68.58 | |
PFCF ratio | -21.13 | -28.42 | -390.99 | -25.49 | -64.78 | |
P/B Ratio | 0.33 | 0.47 | 0.72 | 0.44 | 0.29 | |
PTB ratio | 0.33 | 0.47 | 0.72 | 0.44 | 0.29 | |
EV to sales | 8.54 | 9.35 | 10.28 | 10.15 | 9.84 | |
Enterprise value over EBITDA | -71.36 | -72.28 | 750.41 | -76.36 | -286.79 | |
EV to operating cash flow | -50.49 | -70.68 | -3.49K | -469.22 | 222.09 | |
EV to free cash flow | -46.16 | -69.58 | -850.41 | -66.83 | -209.76 | |
Earnings yield | 0.18 | 0.28 | -0.33 | 0.46 | 0.59 | |
Free cash flow yield | -0.05 | -0.04 | 0 | -0.04 | -0.02 | |
Debt to equity | 0.05 | 0.91 | 1.13 | 0.91 | 0.8 | |
Debt to assets | 0.04 | 0.45 | 0.5 | 0.45 | 0.42 | |
Net debt to EBITDA | -38.69 | -42.76 | 405.4 | -47.23 | -198.22 | |
Current ratio | 2.62 | 3.58 | 3.65 | 3.03 | 3.13 | |
Interest coverage | -2.17 | -1.75 | -0.62 | -1.4 | -0.71 | |
Income quality | -0.24 | -0.12 | 0 | -0.01 | 0.02 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.3 | 0.34 | 0.3 | 0.33 | 0.35 | |
Research and developement to revenue | 0 | 0 | 0 | 0.01 | 0.01 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0.09 | 0.02 | 3.11 | 6.02 | -2.06 | |
Capex to revenue | -0.02 | 0 | -0.01 | -0.13 | -0.09 | |
Capex to depreciation | -0.22 | -0.03 | -0.09 | -1.12 | -0.76 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 0.38 | 0.33 | 0.5 | 0.42 | 0.45 | |
ROIC | -0.02 | -0.01 | -0.01 | -0.01 | -0.01 | |
Return on tangible assets | 0.05 | 0.07 | -0.1 | 0.1 | 0.09 | |
Graham Net | 0.01 | -0.13 | -0.19 | -0.15 | -0.15 | |
Working capital | 128.9M | 150.76M | 153.19M | 130.32M | 121.65M | |
Tangible asset value | 1.06B | 628.56M | 518.27M | 653.95M | 769.98M | |
Net current asset value | 74.13M | -424.44M | -431.27M | -465.15M | -492.62M | |
Invested capital | 0.05 | 0.91 | 1.13 | 0.91 | 0.8 | |
Average receivables | 20.56M | 34.7M | 50.25M | 47.62M | 45.79M | |
Average payables | 7.52M | 7.18M | 6.47M | 6.57M | 6.55M | |
Average inventory | 4.96M | 7.15M | 8.35M | 10.42M | 8.28M | |
Days sales outstanding | 82.01 | 232.2 | 236.86 | 217.7 | 238.84 | |
Days payables outstanding | 74.86 | 65.69 | 67.41 | 64.79 | 58.44 | |
Days of inventory on hand | 53.66 | 89.28 | 82.74 | 126.78 | 34.57 | |
Receivables turnover | 4.45 | 1.57 | 1.54 | 1.68 | 1.53 | |
Payables turnover | 4.88 | 5.56 | 5.41 | 5.63 | 6.25 | |
Inventory turnover | 6.8 | 4.09 | 4.41 | 2.88 | 10.56 | |
ROE | 0.06 | 0.13 | -0.23 | 0.2 | 0.17 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2023-09-30 for Q2
Metric | History | 2021-09-30 | 2022-03-31 | 2022-09-30 | 2023-03-31 | 2023-09-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0.01 | 0.01 | 0.01 | 0.02 | 0.01 | |
Net income per share | 0.03 | 0.01 | 0.02 | 0.03 | -0.1 | |
Operating cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Free cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Cash per share | 0.04 | 0.04 | 0.34 | 0.05 | 0.05 | |
Book value per share | 0.18 | 0.2 | 0.29 | 0.32 | 0.22 | |
Tangible book value per share | 0.18 | 0.2 | 0.29 | 0.32 | 0.22 | |
Share holders equity per share | 0.18 | 0.2 | 0.29 | 0.32 | 0.22 | |
Interest debt per share | 0.18 | 0.18 | 0.26 | 0.26 | 0.26 | |
Market cap | 342.16M | 286.23M | 169.69M | 160.13M | 117.11M | |
Enterprise value | 790.25M | 750.28M | 653.2M | 653.51M | 630.77M | |
P/E ratio | 0.97 | 1.7 | 0.93 | 0.48 | -0.12 | |
Price to sales ratio | 7.87 | 9.4 | 4.98 | 4.16 | 3.89 | |
POCF ratio | -95.36 | 143.91 | -49.23 | 24.04 | -26.46 | |
PFCF ratio | -95.36 | -37.47 | -49.23 | 3.64K | -26.46 | |
P/B Ratio | 0.56 | 0.44 | 0.25 | 0.21 | 0.22 | |
PTB ratio | 0.56 | 0.44 | 0.25 | 0.21 | 0.22 | |
EV to sales | 18.18 | 24.63 | 19.16 | 16.98 | 20.93 | |
Enterprise value over EBITDA | 1.13K | -71.26 | -168.7 | 472.53 | 560.18 | |
EV to operating cash flow | -220.25 | 377.21 | -189.5 | 98.11 | -142.51 | |
EV to free cash flow | -220.25 | -98.22 | -189.5 | 14.85K | -142.51 | |
Earnings yield | 0.26 | 0.15 | 0.27 | 0.52 | -2.03 | |
Free cash flow yield | -0.01 | -0.03 | -0.02 | 0 | -0.04 | |
Debt to equity | 0.97 | 0.91 | 0.88 | 0.8 | 1.18 | |
Debt to assets | 0.47 | 0.45 | 0.45 | 0.42 | 0.52 | |
Net debt to EBITDA | 638.31 | -44.08 | -124.87 | 356.75 | 456.18 | |
Current ratio | 3.6 | 3.03 | 16.19 | 3.13 | 3.49 | |
Interest coverage | -0.55 | -2.18 | -1.07 | -0.38 | -0.37 | |
Income quality | -0.04 | 0.05 | -0.08 | 0.08 | 0.02 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.27 | 0.4 | 0.36 | 0.35 | 0.38 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0 | -4.84 | 0 | -0.99 | 0 | |
Capex to revenue | 0 | -0.32 | 0 | -0.17 | 0 | |
Capex to depreciation | 0 | -2.16 | 0 | -1.47 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 0.33 | 0.24 | 0.35 | 0.5 | 0.7 | |
ROIC | 0 | -0.01 | -0.01 | 0 | 0 | |
Return on tangible assets | 0.07 | 0.03 | 0.03 | 0.06 | -0.2 | |
Graham Net | -0.14 | -0.15 | 0.08 | -0.21 | -0.22 | |
Working capital | 151.53M | 130.32M | 823.33M | 121.65M | 128.06M | |
Tangible asset value | 609.48M | 653.95M | 688.35M | 769.98M | 526.12M | |
Net current asset value | -438.3M | -465.15M | 220.44M | -492.62M | -494.32M | |
Invested capital | 0.97 | 0.91 | 0.88 | 0.8 | 1.18 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 0 | 0 | 0 | 0 | 0 | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 107.07 | 130.27 | 129.19 | 111.07 | 172.78 | |
Days payables outstanding | 25.68 | 34.76 | 24.9 | 28.61 | 34.11 | |
Days of inventory on hand | 30.59 | 68.02 | 18 | 16.92 | 32.84 | |
Receivables turnover | 0.84 | 0.69 | 0.7 | 0.81 | 0.52 | |
Payables turnover | 3.5 | 2.59 | 3.62 | 3.15 | 2.64 | |
Inventory turnover | 2.94 | 1.32 | 5 | 5.32 | 2.74 | |
ROE | 0.15 | 0.06 | 0.07 | 0.11 | -0.45 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
0858.HK Frequently Asked Questions
What is Extrawell Pharmaceutical Holdings Limited stock symbol ?
Extrawell Pharmaceutical Holdings Limited is a HK stock and trading under the symbol 0858.HK
What is Extrawell Pharmaceutical Holdings Limited stock quote today ?
Extrawell Pharmaceutical Holdings Limited stock price is $0.031 today.
Is Extrawell Pharmaceutical Holdings Limited stock public?
Yes, Extrawell Pharmaceutical Holdings Limited is a publicly traded company.